1. Home
  2. XNET vs NNNN Comparison

XNET vs NNNN Comparison

Compare XNET & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xunlei Limited

XNET

Xunlei Limited

SELL

Current Price

$5.00

Market Cap

319.3M

Sector

Technology

ML Signal

SELL

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

BUY

Current Price

$4.49

Market Cap

270.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
XNET
NNNN
Founded
2003
2021
Country
China
Germany
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
319.3M
270.4M
IPO Year
2011
2023

Fundamental Metrics

Financial Performance
Metric
XNET
NNNN
Price
$5.00
$4.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 199.2K
151.2K
Earning Date
11-12-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $0.29
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$4.52
$4.16
52 Week High
$9.77
$44.73

Technical Indicators

Market Signals
Indicator
XNET
NNNN
Relative Strength Index (RSI) 54.10 29.31
Support Level $4.76 N/A
Resistance Level $5.25 $6.95
Average True Range (ATR) 0.16 0.57
MACD 0.02 -0.03
Stochastic Oscillator 77.59 10.55

Price Performance

Historical Comparison
XNET
NNNN

About XNET Xunlei Limited

Xunlei Ltd is a technology company providing distributed cloud services in China. It operates a powerful internet platform in China based on cloud technology to enable its users to quickly access, store, manage and consume digital media content on the internet. The company has expanded its products and services from PC-based devices to mobile devices in part through pre-installed acceleration products in mobile phones to further enlarge its user base and offer its users a wider range of access points. It provides a wide range of products and services across cloud acceleration and digital entertainment to deliver an efficient, smart and safe internet environment to its users.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).

Share on Social Networks: